> ## Content Index
> Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# AHRQ patient-safety research funding quietly halted
- URL: https://members.americanhealthintel.com/2026-08-01-regulator/
- Published: 2026-08-01T09:52:34.000Z
- Updated: 2026-08-01T09:52:34.000Z
- Description: Plus: HRSA expands 340B rebate pilot to 25 drugs, court limits drugmaker rebate models. The day's rules, money, and enforcement, sourced and tiered below.
- Author: American Health Intel

Plus: HRSA expands 340B rebate pilot to 25 drugs, court limits drugmaker rebate models. The day's rules, money, and enforcement, sourced and tiered below.

| American Health Intel Rules · Money · Medicine · Decoded daily The Regulator Saturday, August 1, 2026 AHRQ patient-safety research funding quietly halted Plus: HRSA expands 340B rebate pilot to 25 drugs, court limits drugmaker rebate models. The day's rules, money, and enforcement, sourced and tiered below. ![](https://americanhealthintel.com/email/pulse-divider.png) Report Confidence: Medium The federal agency that studies why U.S. health care costs too much and patients wait too long just got gutted: $345 million appropriated, under $15 million spent, 104 patient-safety grants halted. Agency for Healthcare Research and Quality staff fell from 300 to 74 in 18 months. A researchers' group is suing. Its past work is credited with saving 20,500 lives and $7.7 billion. Why it matters This is about whether the federal government keeps funding the research that identifies unsafe hospital practices before more patients get hurt. Watch whether the lawsuit forces AHRQ to resume grant-making. Sources: [Cbsnews](https://www.cbsnews.com/news/trump-healthcare-safety-agency-ahrq/?ref=members.americanhealthintel.com) · [Kffhealthnews](https://kffhealthnews.org/news/ahrq-funding-grants-trump-healthcare-safety-research-agency-hobbled/?ref=members.americanhealthintel.com) Rule Confidence: Medium The government just expanded its own 340B drug-discount rebate program to 25 drugs from 13 drugmakers, days after a federal court blocked those same drugmakers from building rival rebate plans without permission. HRSA's pilot lets drugmakers pay hospitals back for the 340B discount after purchase instead of upfront, which hospitals say strains cash flow. It grew from 10 covered drugs to as many as 25. Why it matters This is about who fronts the cash for a drug discount meant for safety-net providers, the government's own program or drugmakers acting unilaterally; watch whether more manufacturers join HRSA's voluntary pilot. Sources: [Federal Register](https://www.federalregister.gov/documents/2026/07/31/2026-15633/notice-regarding-340b-rebate-model-pilot-program?ref=members.americanhealthintel.com) · [Aha](https://www.aha.org/news/headline/2026-07-21-court-rules-companies-may-not-impose-340b-rebate-model-without-hhs-approval?ref=members.americanhealthintel.com) Also today Medicaid work requirements take legal effect [Read](https://americanhealthintel.com/editions/2026-08-01-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#massachusetts-v-oz-medicaid-work-requirements-hearing) PAMA clinical lab data deadline, $10K/day penalty [Read](https://americanhealthintel.com/editions/2026-08-01-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#pama-clinical-lab-reporting-deadline) NY nursing home chain still violating $45M Medicaid fraud settlement [Read](https://americanhealthintel.com/editions/2026-08-01-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#ny-centers-health-care-settlement-violation) 349Records$26.7BEnforcement18Deadlines106Rules [Read this issue + the trackers](https://americanhealthintel.com/editions/2026-08-01-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) Pick your field on the site and every story tells you what it means for you. Reply to this email and tell us what you want covered. We read everything. We show our work. We score our own calls. [Track record](https://americanhealthintel.com/ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Calendar](https://americanhealthintel.com/calendar/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Enforcement](https://americanhealthintel.com/enforcement/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [X](https://x.com/amhealthintel?ref=members.americanhealthintel.com) · [LinkedIn](https://www.linkedin.com/company/american-health-intel?ref=members.americanhealthintel.com) News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) |
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |